Unresectable Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Unresectable Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Entinostat in combination with ZEN003694 for advanced solid tumors, including locally advanced and metas…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer [NA]
This update describes a feasibility and safety study of intratumoral diffusing alpha radiation emitters for advanced pancreatic cancer. The …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy [NA]
This clinical trial update describes PROACTIVE, a study assessing surgical resection outcomes after neoadjuvant chemotherapy in locally adva…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer [Phase 2]
A Phase 2b trial evaluating GC4711 in combination with SBRT for nonmetastatic pancreatic cancer was terminated, with results posted in May 2…
-
CLINICAL_TRIALS research · 2022-01-11Clinical Trial Update: EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options [NA]
Clinical trial update for EL CENTRO, focusing on engaging Latinos in cancer treatment decisions; trial status completed with posted results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer [Phase 2]
Phase II clinical trial evaluating mFOLFIRINOX with SBRT for unresectable locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Improving Informed Consent for Palliative Chemotherapy [NA]
A completed trial evaluating improvements to informed consent for palliative chemotherapy in metastatic colorectal and pancreatic cancers.